Enliven Therapeutics (NASDAQ:ELVN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Enliven Therapeutics Stock (NASDAQ: ELVN) stock price, news, charts, stock research, profile.

Open	$23.51
Close	$23.37
Volume / Avg.	2.54M / 365.80K
Day Range	22.99 - 24.24
52 Wk Range	9.80 - 26.00
Market Cap	$1.10B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	29.38%
Days to Cover	31.93

Recent News

Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program

Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data.

Vandana Singh

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Avi Kapoor

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Enliven Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Enliven Therapeutics (ELVN) stock?

You can purchase shares of Enliven Therapeutics (NASDAQ:ELVN) through any online brokerage.

View our list of the best stock brokerages

Who are Enliven Therapeutics (ELVN) competitors?

Other companies in Enliven Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Phibro Animal Health (NASDAQ:PAHC).

What is the target price for Enliven Therapeutics (ELVN) stock?

There is no analysis for Enliven Therapeutics.

What is the forecast for Enliven Therapeutics (ELVN) stock?

Enliven Therapeutics has a consensus price target of $23.25.

Current stock price for Enliven Therapeutics (ELVN)?

The stock price for Enliven Therapeutics (NASDAQ: ELVN) is $23.37 last updated June 28, 2024 at 4:19 PM EDT.

Does Enliven Therapeutics (ELVN) pay a dividend?

There are no upcoming dividends for Enliven Therapeutics.

When is Enliven Therapeutics (NASDAQ:ELVN) reporting earnings?

Enliven Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Enliven Therapeutics (ELVN) going to split?

There is no upcoming split for Enliven Therapeutics.

What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Enliven Therapeutics

Enliven Therapeutics (ELVN) Forecast